About the Editors
Principal Editor
Robin Emsley, DMed, DSc, Faculty of Medicine and Health Sciences, University of Stellenbosch, South Africa
Robin Emsley is Professor Emeritus in Psychiatry in Faculty of Medicine and Health Sciences at University of Stellenbosch, Cape Town, South Africa. He holds Doctoral degrees in Medicine and in Science for studies in schizophrenia. Previously, he was Executive Head of the Department of Psychiatry for 23 years. His main interests are in the clinical, neurobiological and pharmacological aspects of schizophrenia.
Associate Editors
Daniel Martins-de-Souza, PhD, Institute of Biology, University of Campinas (UNICAMP), Brazil
Daniel Martins-de-Souza is a Professor of Biochemistry and heads the Laboratory of Neuroproteomics, where his group employs proteomic tools to investigate molecular mechanisms involved in psychiatric disorders and the identification of potential biomarkers. Daniel has been elected as an Affiliated Member of the Brazilian Academy of Sciences (ABC), and is a scientific member of the two major scientific funding agencies in Brazil (FAPESP and CNPq). In 2023, Daniel was awarded the "SIRS Basic Research Award".
Cheryl M. Corcoran, MD, Icahn School of Medicine in Mount Sinai, United States
Cheryl Corcoran is Associate Professor and Program Leader in Psychosis Risk at the Icahn School of Medicine at Mount Sinai. Dr. Corcoran’s area of expertise is in early psychosis. Dr. Corcoran co-developed the SIPS/SOPS and founded two prospective psychosis risk cohort studies, first at Columbia and now at Mount Sinai. Her work encompasses psychosis risk, natural language processing, sensory processing (auditory/visual/olfactory), social cognition, neuroimaging, clinical correlates, cannabis/stress exposures, nosology, ethics/stigma, clinical trials and services.
Editorial Board Members
Celso Arango, MD, PhD, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Spain
Kristen Brennand, PhD, Wu Tsai Institute at Yale, and Yale Stem Cell Center, Yale University School of Medicine, USA
Michael Davidson, MD, Nicosia University Medical School, Israel
Paola Dazzan, MD, PhD, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom
Lynn E. DeLisi, MD, Cambridge Health Alliance and Harvard Medical School, United States
Kim Q. Do, PhD, Faculty of Biology and Medicine, Lausanne University Hospital, Switzerland
Enrico Domenici, PhD, Centre for Integrative Biology, University of Trento, Italy
Erica Duncan, MD, Emory University School of Medicine, United States
Diane Gooding, PhD, University of Wisconsin-Madison, United States
Anthony Grace, PhD, University of Pittsburgh, United States
René S. Kahn, MD, PhD, Icahn School of Medicine at Mount Sinai, Netherlands
Kiyoto Kasai, MD, PhD, Graduate School of Medicine, The University of Tokyo, Japan